About Us
ISO 17025 accredited WMINOLAB Innovation Laboratory provides services in a leading position in pharmaceutical drug analysis and specific studies with long-standing RD experience and scientific approaches. WMINOLAB aims to increase product quality and standards by producing technological knowledge through innovation and is moving towards becoming an analytical solution partner on a global scale.
Extractables Leachables, Nitrosamine Determination, Elemental Impurity Determination which are within the scope of accreditation and a wide variety of studies that can be performed to ensure product quality by meeting the national and international pharmaceutical registration application requirements
WMINOLAB effectively manages the uncertainties in the product development process and meets customer expectations and needs on time through continuous communication and cooperation. It is based on adhering to the principles of impartiality, independence, equality, confidentiality and protection of proprietary in the services
RD Experience and Expert Team
Competence in Ensuring Full Compliance with Legisla
Analytical Reports that Meet the Pharmaceutical Dossier Requirements
Reliable and Accurate Analysis with State-of-Art Facilities and Devices
Vision Mission
Vision
To become a leading, reference laboratory in this field with our service understanding and collaborations in all the countries where we operate
Mission
Through RD and innovation, in line with sustainable quality standards; to produce technological and innovative knowledge, to continuously improve the quality of service, to meet customer demands and expectations at the highest level by adhering to the principles of confidentiality and impartiality, and to be a reliable business partner